PExA AB

Equities

PEXA B

SE0007412374

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
0.373 ^SEK	+8.12%		+3.61%	-9.90%

Feb. 21	PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 21	PExA AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

February 21, 2024 at 02:30 am EST

PExA AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.544461 million compared to SEK 2.07 million a year ago. Net loss was SEK 2.28 million compared to SEK 0.522026 million a year ago.

Latest news about PExA AB

PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
PExA AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
PExA AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
PExA AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
PExA AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
PExA AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-23	CI
PExA AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
PExA AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI
PExA AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-03	CI
PExA AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-24	CI
PExA AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
Pexa AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Pexa AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-26	CI
PExA Enters into Research Collaboration Agreement with Janssen and the University of Gothenburg for Discovery of Biomarkers in Exhaled Air	19-10-02	CI
PExA AB has completed an IPO in the amount of SEK 7.65 million.	15-10-06	CI
PExA AB has filed an IPO.	15-09-14	CI

Chart PExA AB

Duration

Period

More charts

Company Profile

PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PEXA AB	-9.90%	1.44M
SARTORIUS AG	-12.42%	19.22B
QUIDELORTHO CORPORATION	-46.59%	2.63B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+17.50%	1.86B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.58%	1.66B
BIOTAGE AB	+25.36%	1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-8.67%	1.05B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.91%	894M
REVENIO GROUP OYJ	-4.42%	740M
VAREX IMAGING CORPORATION	-17.51%	687M

Medical Diagnostic & Testing Equipment